This inventor holds 2 USPTO granted patents. Top assignee: Kibow Biotech, Inc.. Active years: 2004-2006.
Company Filing History:
Years Active: 2004-2006
Title: Innovations by Nataragan Ranganathan
Introduction
Nataragan Ranganathan is an accomplished inventor based in Broomall, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic compositions aimed at improving health outcomes for patients with renal failure and other conditions.
Latest Patents
Ranganathan holds two notable patents. The first patent is for "Oral bacteriotherapy compositions and methods." This invention provides a composition for the treatment of renal failure using selected bacteria that convert nitrogenous waste into non-toxic compounds in vivo. It also includes a method for inhibiting the buildup of toxins and metabolic wastes, as well as controlling the overgrowth of undesirable bacteria in a subject by administering the composition. The second patent is for "Prebiotic and probiotic compositions and methods for their use in gut-based therapies." This invention features microencapsulated and/or enteric-coated compositions containing a mixture of probiotics, prebiotics, and ammoniaphilic bacteria with high urease activity. These compositions are designed to alleviate symptoms of uremia in patients by administering them orally.
Career Highlights
Ranganathan is currently associated with Kibow Biotech, Inc., where he continues to innovate and develop new therapeutic solutions. His work focuses on enhancing the quality of life for patients suffering from renal and gut-related issues.
Collaborations
Some of his notable coworkers include Jack Dickstein and Raj J Mehta, who contribute to the collaborative efforts at Kibow Biotech, Inc.
Conclusion
Nataragan Ranganathan's innovative work in biotechnology has led to significant advancements in the treatment of renal failure and gut health. His patents reflect a commitment to improving patient care through scientific research and development.